GlassScriptPhysician profile
Arnold Samuel Castro
NPI 1407325582
$2,061.56
in general payments reported to CMS, 2019-2025
21 companies · $711 in 2025
The $711 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $297 · 2023: $483 · 2024: $357 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.73 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $294.02 | 2023-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $216.74 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $215.19 | 2022-2025 | Airsupra |
| Corcept Therapeutics | $174.07 | 2022-2023 | Korlym |
| Janssen Biotech, INC. | $170.37 | 2024-2025 | Erleada |
| Astellas Pharma US INC | $158.05 | 2021-2024 | Veozah |
| Sumitomo Pharma America, INC. | $132.07 | 2024-2025 | Gemtesa |
| Globus Medical, INC. | $129.47 | 2025 | Senza |
| Myriad Genetic Laboratories, INC. | $108.65 | 2021-2025 | Prolaris |
| Urogen Pharma, INC. | $105.13 | 2023-2025 | Jelmyto |
| Pfizer INC. | $97.36 | 2021-2025 | |
| Myovant Sciences INC. | $71.60 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $27.93 | 2022 | |
| Access Pro Medical, LLC | $27.75 | 2025 | Matriderm |
| Endo USA, INC. | $24.89 | 2024 | Xiaflex |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $24.40 | 2025 | Isturisa |
| Endo Pharmaceuticals INC. | $20.70 | 2023 | Xiaflex |
| Daiichi Sankyo INC. | $18.72 | 2022 | |
| Foundation Medicine, INC. | $17.33 | 2023 | |
| Cranial Technologies, INC | $14.13 | 2023 | Doc Band |
| 180 Medical, INC. | $12.99 | 2023 | Gentlecath Glide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.